In Acute Severe Ulcerative Colitis Patients Who Receive Rescue Therapy, Prior Maintenance Therapy and Day 3 C-Reactive Protein After Rescue Therapy Are Associated With 12-Month Colectomy Risk
Overview
Overview
Journal
Inflamm Bowel Dis
Publisher
Oxford University Press
Specialty
Gastroenterology
Date
2023 Sep 22
PMID
37738577
Authors
Affiliations
Affiliations
Soon will be listed here.
Citing Articles
C-Reactive Protein Is Not the Driver Factor in Ulcerative Colitis.
Ge Z, Zhang X, Zhang C, Xu T, Li S, Wei M Gastroenterol Res Pract. 2024; 2024:1386147.
PMID: 39380742 PMC: 11461073. DOI: 10.1155/2024/1386147.
References
1.
Williams J, Alam M, Alrubaiy L, Arnott I, Clement C, Cohen D
. Infliximab versus ciclosporin for steroid-resistant acute severe ulcerative colitis (CONSTRUCT): a mixed methods, open-label, pragmatic randomised trial. Lancet Gastroenterol Hepatol. 2016; 1(1):15-24.
PMC: 4994668.
DOI: 10.1016/S2468-1253(16)30003-6.
View
2.
Dwadasi S, Zafer M, Goens D, Paknikar R, Dalal S, Cohen R
. Inpatient Therapy With Calcineurin Inhibitors in Severe Ulcerative Colitis. Inflamm Bowel Dis. 2020; 27(10):1620-1625.
PMC: 8682443.
DOI: 10.1093/ibd/izaa326.
View
3.
Shah S, Naymagon S, Panchal H, Sands B, Cohen B, Dubinsky M
. Accelerated Infliximab Dosing Increases 30-Day Colectomy in Hospitalized Ulcerative Colitis Patients: A Propensity Score Analysis. Inflamm Bowel Dis. 2018; 24(3):651-659.
DOI: 10.1093/ibd/izx039.
View
4.
Kohn A, Daperno M, Armuzzi A, Cappello M, Biancone L, Orlando A
. Infliximab in severe ulcerative colitis: short-term results of different infusion regimens and long-term follow-up. Aliment Pharmacol Ther. 2007; 26(5):747-56.
DOI: 10.1111/j.1365-2036.2007.03415.x.
View
5.
Gibson D, Heetun Z, Redmond C, Nanda K, Keegan D, Byrne K
. An accelerated infliximab induction regimen reduces the need for early colectomy in patients with acute severe ulcerative colitis. Clin Gastroenterol Hepatol. 2014; 13(2):330-335.e1.
DOI: 10.1016/j.cgh.2014.07.041.
View